Related Experiment Video
Updated: Jan 21, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Management of methicillin-resistant Staphylococcus aureus mediated ventilator-associated pneumonia
Manisha Dahal1, William R Schwan1
1University of Wisconsin-La Crosse, La Crosse, WI.
Abstract:
Prevention strategies and clinical management of methicillin- resistant Staphylococcus aureus (MRSA) infections in ventilated patients who develop ventilator-associated pneumonia (VAP) are important. Since MRSA are the most frequently isolated bacteria in patients with VAP, and a significant cause of morbidity and mortality in intubated patients, rapid diagnosis and early treatment could reduce mortality. This review will examine preventive steps (i.e. screening ventilated patients for MRSA, decolonization, and hand washing), assessing clinical presentations before the results of culture are obtained to direct empiric treatment, and the appropriate antibiotic therapy upon culture confirmation of MRSA that could help in the management of VAP.
Insights
This review focuses on preventing and managing methicillin-resistant Staphylococcus aureus (MRSA) in ventilated patients with pneumonia. Early detection and treatment are crucial for reducing mortality in these high-risk individuals.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of ventilator-associated pneumonia (VAP) in intubated patients.
- MRSA-VAP significantly increases patient morbidity and mortality.
- Effective prevention and management strategies are critical.
Purpose of the Study:
- To review preventive measures for MRSA in ventilated patients.
- To discuss clinical assessment for empiric treatment decisions.
- To outline appropriate antibiotic therapies for confirmed MRSA-VAP.
Main Methods:
- Literature review of prevention and management strategies for MRSA-VAP.
- Analysis of clinical presentations and diagnostic approaches.
- Evaluation of antibiotic treatment guidelines.
Main Results:
- Preventive strategies include MRSA screening, decolonization, and hand hygiene.
- Empiric treatment should be guided by clinical presentation pending culture results.
- Culture-confirmed MRSA-VAP requires specific antibiotic selection.
Conclusions:
- Comprehensive strategies combining prevention, early diagnosis, and targeted therapy are essential for managing MRSA-VAP.
- Reducing MRSA-VAP incidence and mortality requires a multi-faceted approach.
- Adherence to evidence-based guidelines improves patient outcomes.
More Related Videos
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology

